Atlas Trials

Assessing the Safety and Ability of SG1002 to Overcome Deficits in Hydrogen Sulfide in Heart Failure Patients

Clinical trial NCT01989208 · COMPLETED

Trial details

NCT number
NCT01989208
Sponsor
Sulfagenix Australia Pty Ltd.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Heart Failure
Start date
2014-01-01
Primary completion
2014-12-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.